Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2019
Arrowhead appoints Marianne De Backer to its board
Arrowhead Pharmaceuticals announced that its board appointed Marianne De Backer as an independent director, effective immediately.
2019
Arrowhead Pharmaceuticals prices public stock offering
Arrowhead Pharmaceuticals announced the pricing of an underwritten public offering of 4 million common shares at $58 per share. The offering was expected to close on or about December 6, 2019, subject to customary closing conditions.